Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I G M Lancisi G Salesi

The medical center is at the forefront of research in gastroenterology, focusing on innovative treatments for ulcerative colitis in pediatric populations. The center's work aims to enhance the induction of remission and maintain therapeutic effects in children and teenagers.

• Ulcerative Colitis in Pediatrics

Through cutting-edge clinical trials, the center is pioneering new approaches to manage and treat chronic gastrointestinal conditions in younger patients.

Specializing in hematology and oncology, the center conducts extensive research on Langerhans Cell Histiocytosis and Acute Myeloid Leukemia. The focus is on reducing mortality and improving treatment outcomes through novel therapeutic strategies.

• Langerhans Cell Histiocytosis
• Acute Myeloid Leukemia

The center's research contributes significantly to the development of personalized medicine approaches, enhancing patient survival and quality of life.

In the field of immunology, the center is advancing the understanding and treatment of neutropenias and septic shock. Research efforts are directed towards improving infection management and reducing mortality through innovative therapies.

• Chronic Neutropenia
• Septic Shock

By exploring new therapeutic avenues, the center aims to enhance immune system function and patient outcomes in severe infectious conditions.

The center is a leader in respiratory medicine, focusing on idiopathic pulmonary fibrosis. Research is dedicated to evaluating new treatments that improve lung function and patient quality of life.

• Idiopathic Pulmonary Fibrosis

Through rigorous clinical trials, the center is paving the way for more effective management of chronic respiratory diseases.

In the realm of neurology, the center is exploring treatments for hypoxic-ischemic encephalopathy in newborns. The research focuses on reducing neurodevelopmental impairments through innovative therapeutic interventions.

• Hypoxic-Ischemic Encephalopathy

The center's work is crucial in developing strategies to improve neurological outcomes in affected infants.